Table 2.
Clinical effects | |
---|---|
Acute hypoxaemic respiratory failure | • Reduces dyspnoea • Improves oxygenation • Decreases escalation to invasive support |
Hypoxaemic failure in immunocompromised patients | • Reduces dyspnoea • Improves oxygenation • Reduces intubation rate • Reduces mortality (?) |
Cardiogenic pulmonary oedema | • Improves oxygenation • Reduces cardiac afterload |
Exacerbation of chronic obstructive pulmonary diseases | • Improves gas exchange • Decreases partial pressure of CO2 |
Postextubation | • Improves gas exchange • Decreases reintubation rates |
Respiratory procedures | • Improves oxygenation during endoscopy |